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Abstract
Toxoplasma gondii is a human pathogen prevalent worldwide that poses a challenging and
unmet need for novel treatment of toxoplasmosis. Using a semi-automated reconstruction
algorithm, we reconstructed a genome-scale metabolic model, ToxoNet1. The reconstruc-
tion process and flux-balance analysis of the model offer a systematic overview of the meta-
bolic capabilities of this parasite. Using ToxoNet1 we have identified significant gaps in the
current knowledge of Toxoplasmametabolic pathways and have clarified its minimal nutri-
tional requirements for replication. By probing the model via metabolic tasks, we have fur-
ther defined sets of alternative precursors necessary for parasite growth. Within a human
host cell environment, ToxoNet1 predicts a minimal set of 53 enzyme-coding genes and 76
reactions to be essential for parasite replication. Double-gene-essentiality analysis identi-
fied 20 pairs of genes for which simultaneous deletion is deleterious. To validate several
predictions of ToxoNet1 we have performed experimental analyses of cytosolic acetyl-CoA
biosynthesis. ATP-citrate lyase and acetyl-CoA synthase were localised and their corre-
sponding genes disrupted, establishing that each of these enzymes is dispensable for the
growth of T. gondii, however together they make a synthetic lethal pair.
Author Summary
Understanding the metabolism of disease-causing microorganisms can guide drug design
through the identification of metabolic enzymes whose activity is indispensable for impor-
tant cellular functions. Such understanding can come from the reconstruction and compu-
tational analysis of metabolic networks. In this study we have focused on the metabolism
of an opportunistic human pathogen, Toxoplasma gondii, which chronically infects about
30% of humans worldwide. Through a semi-automatic reconstruction we have developed
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ToxoNet1, a comprehensive metabolic model of Toxoplasma gondii, and we have per-
formed an extensive computational analysis to explore the properties of Toxoplasmame-
tabolism. In particular, we have identified and classified the minimal set of substrates the
parasite utilizes for growth, along with the genes and pairs of genes that are essential for
cellular functions such as growth and energy metabolism. We have validated our computa-
tional predictions that the genes encoding acetyl-CoA synthase and ATP-citrate lyase en-
zymes serve complementary function but their simultaneous disruption does not allow
cell growth. This study presents a number of hypotheses generated using ToxoNet1, which
can lead to the discovery of novel antiparasitic drug targets.
Introduction
The phylum of Apicomplexa comprises a large number of obligate intracellular parasites that
can infect organisms across the whole animal kingdom. An important member of this phylum,
Toxoplasma gondii, is a ubiquitous opportunistic pathogen responsible for one of the most
common parasitic infections in humans and warm-blooded animals. It is estimated that up to
30% of the human population is chronically infected [1]. Toxoplasmosis is largely asymptom-
atic in healthy adults but can cause severe disease or even death in immunocompromised indi-
viduals and can lead to complications in development of the foetus, if primary infection occurs
during pregnancy [2].
T. gondii possesses a complex life cycle, which is composed of an asexual replicative stage in
the intermediate host and a sexually replicative stage within the definitive feline host. During
the asexual phase, T. gondii can switch from a fast-replicative tachyzoite form, which causes
acute disease, to a slow-growing bradyzoite stage, which forms cysts that are characteristic of
chronic infection. The encysted, slow growing form is resistant to commonly used drugs and
immune system attack. Few efficient medicines are available to treat toxoplasmosis and they
mainly treat the acute phase of the disease. Furthermore, poor tolerance of these drugs pro-
motes the search for novel drug targets.
Unlike other notorious apicomplexan parasites that infect a narrow range of host cell types,
such as the Plasmodium species, T. gondii is able to invade and asexually replicate within virtu-
ally any nucleated cell of warm-blooded animals. The broad range of cells amenable to infec-
tion by T. gondii reflects the plasticity of the parasite’s metabolism and versatility in accessing
and utilising nutrients to support its intracellular growth [3,4]. The complexity of decoupling
the metabolic processes of this intracellular pathogen from those of the infected host limits the
depth of our understanding about the metabolic capabilities of T. gondii.
Currently, no adequate experimental approaches exist to answer comprehensively the fol-
lowing important questions: 1) what substrates are available within the host cell that are neces-
sary for T. gondii replication and which of these are dispensable; 2) in which intracellular
compartments do the enzymatic activities annotated at the genome level occur; 3) which of
these enzymatic activities are indispensable for replication or other vital processes of the para-
site. While achievable, the application of high-throughput gene knockout or knockdown strate-
gies to globally determine gene essentiality in T. gondii remains a major undertaking.
Computational (i.e. in silico) metabolic modelling coupled with systematic analyses facili-
tates the study of biological systems. This modern approach of systems biology has been exten-
sively exerted to predict gene essentiality in various bacteria, including numerous pathogenic
species [5]. In silicometabolic models offer a cost-effective pipeline to identify putatively indis-
pensable metabolic processes that, in the case of pathogens, represent potential targets for
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therapeutic intervention [6]. Recently, models have been constructed for eukaryotic pathogens
including for members of the phylum Apicomplexa [7–10].
In this study we have reconstructed a genome-scale metabolic model of T. gondii, ToxoNet1,
aiming to address the abovementioned questions in a systematic way and to the extent possible
with the currently available knowledge. Using flux-balance analysis we have identified genes,
reactions and pairs of genes for which deletion renders production of biomass components im-
possible. Furthermore, we have assessed which precursors are necessary for each of the biomass
components and have defined minimal sets of such precursors that allow in silico simulation of
growth. To illustrate the applicability of ToxoNet1 in filling knowledge gaps regarding parasite
metabolism, we experimentally challenged the model prediction regarding the alternative
routes for generation of cytosolic acetyl-CoA. We have confirmed in vitro the functional re-
dundancy and synthetic lethality of the two biosynthetic routes that involve the ATP-citrate
lyase and acetyl-CoA synthase enzymes.
Results
Here we present the full genome-scale in silico reconstruction of metabolism in T. gondii with
manually refined gene-reaction associations—ToxoNet1. The model reconstruction process re-
quired completion of the following major steps (schematically shown in Fig 1): (1) reconstruc-
tion of the draft metabolic network; (2) compartmentalization of the intracellular space; (3)
verification of the metabolic capabilities and manual literature-based corrections; (4) represen-
tation of the plausible exchanges of metabolites between the infected host cell and the parasite.
In general terms, the reconstruction process was consistent with the workflow that has been
previously used for semi-automated reconstruction of a genome-scale metabolic model for
Penicillium chrysogenum by means of the RAVEN Toolbox [11]. All the necessary manual cor-
rections were made in accordance to the conventional model reconstruction protocol [12].
For the compartmentalization process we consulted the models of Plasmodium falciparum
[9,13] and used sequence-based predictors of subcellular localization [14–16] as well as the
ApiLoc (http://apiloc.biochem.unimelb.edu.au/apiloc/apiloc) database. The databases used for
identification of “gap” reactions were KEGG [17] and LLAMP [18]. Recon 2 [19] was used as a
model of host cell metabolism to define the list of putatively host-supplied substrates.
Reconstruction of the ToxoNet1
Reconstruction of the metabolic network was achieved by combination of the state-of-the-art
algorithm for a semi-automated generation of metabolic networks [11] and a comprehensive
manual curation based on the relevant primary literature. Details of the reconstruction process
are provided in the materials and methods section and the most important steps are discussed
below.
The reconstructed metabolic network accounted for 527 open-reading frames (ORFs) that
were linked to 867 unique metabolic reactions present in the KEGG [17] database. Each func-
tional annotation in the model was assigned with two estimates (namely a bit-score and e-value),
which indicated confidence of association for a given ORF with a corresponding enzymatic
function.
In ToxoNet1, the majority of reactions were associated with genes that encode correspond-
ing metabolic enzymes (Fig 2A). Intracellular metabolic reactions not associated with any
genes comprised only 9.6% of all the metabolic reactions present in the model (6.7% of all the
reactions in the model); they include spontaneous reactions (not enzyme-catalysed) and so-
called gap-filling reactions that were added for correct functioning of the model. Most of the
Metabolic Needs and Capabilities of T. gondii
PLOS Computational Biology | DOI:10.1371/journal.pcbi.1004261 May 22, 2015 3 / 28
Fig 1. Reconstruction workflow for ToxoNet1 summarized as a flowchart illustration.
doi:10.1371/journal.pcbi.1004261.g001
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metabolite transport reactions, which were added to connect pathways segregated between
subcellular compartments, also lacked known gene associations.
Among the metabolic enzymes encoded in the genome of T. gondii and present within Tox-
oNet1, the transferases (class 2) and oxidoreductases (class 1) were the most numerous (over
60% of all the enzymes). Hydrolases (class 3), lyases (class 4) and ligases were significantly less
represented (Fig 2B). The least frequent were isomerases (class 5), which is in accordance with
the models of other pathogens, such as Leishmania major [20] and Plasmodium falciparum [8].
Compartmentalization of the ToxoNet1
Relatively straightforward experimental methods exist to determine the localization of proteins
in T. gondii [21], however, it would be laborious and expensive to apply such methods for hun-
dreds of enzymes. According to the ApiLoc database (http://apiloc.biochem.unimelb.edu.au/
apiloc/apiloc), experimental data was available only for a limited number of proteins: 60 out of
the 527 included in ToxoNet1. Thus the only reasonable option for building a compartmental-
ized metabolic model was to make use of sequence-based localization predictors. To define pu-
tative localizations of the enzymes with no experimental evidence we generated sequence-
based predictions using three software algorithms: TargetP [16], MitoProt II [15], and Api-
coAP [14]. We then manually reconciled output data of the three independent predicting algo-
rithms and assigned the localization based on the manually determined consensus prediction,
also considering recent primary literature whenever it was available (S1 Table).
Comparison of these predictions with 60 experimentally established subcellular localiza-
tions available from ApiLoc uncovered two issues: (i) not all the computational predictions
matched their experimental data (highlighted in the S1 Table); (ii) some of the enzymes were
reported to be present in two and, in one case (glutathione/thioredoxin peroxidase [22]), three
different subcellular compartments defined in ToxoNet1. In these cases the sequence-based
predictors were not efficient and suggested only one of the compartments. Therefore, we as-
signed compartments in a supervised manner considering all available evidence.
The information on compartmentalisation organised according to the global metabolic sub-
systems of ToxoNet1 is shown in the Table 1.
Fig 2. Breakdown of the metabolic network. A) By presence of gene-reactions association; B) By enzyme classes encoded in the genome of T. gondii (EC
nomenclature, class 1: oxidoreductases, class 2: transferases, class 3: hydrolases, class 4: lyases, class 5: isomerases, class 6: ligases).
doi:10.1371/journal.pcbi.1004261.g002
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In ToxoNet1 a majority of the reactions (c.a. 69%) occur in the cytosolic compartment. We
also considered this compartment as a default for enzymes with a subcellular localization re-
maining unclear from the in silico predictions. The mitochondrion accommodates 19% of all
metabolic reactions of the model. The remaining 12% are localized to the apicoplast, a plastid-
like non-photosynthetic organelle [23]. We connected these two compartments to the cytosol
by 223 transport reactions. This enabled the corresponding number of metabolites to be trans-
ported across these boundaries, which delineate the organellar membranes (for further details
see the materials and methods section). We allowed the metabolites present in the mitochon-
drion or apicoplast to be reversibly transported to and from the cytosol if they satisfied the fol-
lowing requirements: (i) metabolite has to be present (i.e. participate in at least one reaction) in
both the cytosol and corresponding non-cytosolic compartment; (ii) it should be neither phos-
phorylated nor containing an acyl-carrier-protein or CoA moiety, unless supporting evidence
of such transport is available. We also allowed: (i) import of phosphoenolpyruvate and dihy-
droxyacetone phosphate from the cytosol to the apicoplast [24]; (ii) export of ATP from the
mitochondrion to the cytosol (TGME49_249900); (iii) export of isopentenyl pyrophosphate
(IPP) and dimethylallyl pyrophosphate (DMAPP) from the apicoplast to the cytosol. The latter
allowed us to observe an unusual feature of the isoprenoid biosynthesis pathway in T. gondii re-
garding the isopentenyl pyrophosphate isomerase (EC 5.3.3.2). This enzyme interconverts IPP
into its more reactive isomer—DMAPP. In T. gondii, as well as in Plasmodium spp. this enzyme
is absent [25]. Thus, both IPP and DMAPP have to be produced and transported from the api-
coplast as separate entities for synthesis of long isoprenoid chains in the cytosol.
Verification of the metabolic capabilities of ToxoNet1
Amajor limitation of all algorithms for automatic reconstruction of metabolic models is the
number of missing reactions (so-called gaps) that disrupt metabolic pathways. The RAVEN
Toolbox offers a functionality called metabolic tasks (checkTasks and fitTask functions), which
verifies that specific tasks are fulfilled and, if necessary, it fills the gaps in the metabolic path-
ways to meet the required functionality.
We created metabolic tasks for the synthesis of every metabolite included in the biomass re-
action (complete formulation of all the tasks is provided in the S2 Table). The outcomes of the
tasks were categorized in three groups shown in Table 2. The first group contains the metabo-
lites that could be produced from glucose and inorganic compounds (i.e. de novo synthesis was
possible in the model). The second group contains the metabolites whose synthesis required a
precursor with a specific moiety (e.g. hypoxanthine or other source of purine moiety for purine
nucleotides and their derivatives). The third group are the biomass constituents that could not
Table 1. Breakdown of ToxoNet1 by metabolic subsystems and subcellular compartments.
Metabolic subsystems Genes Reactions Reactions by compartments (non-unique)
(unique) cytosol mitochondrion apicoplast
Carbohydrates 88 114 101 32 16
Amino acids 105 163 140 56 8
Nucleic acids 74 105 93 8 19
Fatty acids 50 99 59 41 45
Vitamins, Co-factors 78 114 111 29 22
Phospholipids 34 42 44 3 2
Miscellaneous 98 230 194 38 28
Total 527 867 742 207 140
doi:10.1371/journal.pcbi.1004261.t001
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be produced even with the maximum set of host-supplied substrates, and therefore they were
directly taken up from the host (e.g. choline, arachidonic acid, cholesterol).
According to ToxoNet1, T. gondii has the capability to produce de novo a number of bio-
mass precursors such as pyrimidine nucleotides and their derivatives, fatty acids, isoprenoids
and about half of the proteinogenic amino acids (Table 2). When tasks of de novo production
for certain biomass constituents failed we attempted to produce them by supplying additional
precursors. In some cases uptake of one or more molecule(s) from the list of host-supplied
molecules, enabled production of the necessary biomass precursors in ToxoNet1. Nevertheless,
several biomass building blocks could not be produced in the model even when all the 230
host-supplied substrates were provided simultaneously, indicating that the parasite is likely
auxotrophic for these molecules.
In the cases when metabolic tasks could not be accomplished despite literature evidence
(mainly acquired from the LLAMP database [18]), we performed gap-filling. This is a conven-
tional part of building genome-scale metabolic models [12] and it implies inclusion of a
Table 2. Nutritional requirements of T. gondii predicted in silico.
Produced de novo (from glucose and inorganic
substrates)
Production requires speciﬁc precursors
(secondary production)
No production from
any of the available
precursors
Amino acids Alanine; Asparagine; Aspartate; Cysteine; Glutamate;
Glutamine; Proline; Serine; Threonine
Tyrosine1; Glycine2; Lysine3; Valine4; Leucine5;
Isoleucine6; Methionine7,8; Phenylalanine8
Arginine; Histidine;
Tryptophan
Nucleotides dCTP; dTTP; CTP; UTP dATP9; dGTP9; ATP9; GTP9
Fatty acids Dodecanoate; Tetradecanoate; Octadecanoate;
Hexadecanoate; Octadecenoate
Linoleate;
Arachidonate
Cofactors Pyridoxal phosphate; Protein-N6-(lipoyl)lysine[apicoplast]15 Glutathione2, 9; CoA9,10; FMN11; NAD9,12
NADP9, 12; Thiamin diphosphate13; S-Adenosyl-
L-methionine2, 7,9; Protein N6-(lipoyl)lysine
[mitochondrial]16; Tetrahydrofolate2;
Tetrahydrobiopterin14
Other
membrane
precursors
UDP-N-acetyl D-glucosamine; Geranylgeranyl-PP;
Undecaprenyl-PP;
PhosphatidylethanolaminePhosphatidylserine
Phosphatidylcholine17; Sphingomyelin17; ADP-
glucose3 GDP-mannose2; 1-Phosphatidyl-D-
myo-inositol18
Cholesterol
Required precursors:
1
—phenylalanine or phenylpyruvate;
2
—folic acid or its derivatives;
3
—l-2-aminoadipate 6-semialdehyde;
4
–3-methyl-2-oxobutanoic acid;
5
–4-methyl-2-oxopentanoate;
6
–(s)-3-methyl-2-oxopentanoic acid;
7
—l-homocysteine;
8
—phenylpyruvate;
9
—a source of purine moiety: hypoxanthine, adenine, adenosine or similar;
10
—pantothenate or valine+β-alanine;
11
—riboﬂavin;
12
—nicotinic acid or its derivatives;
13
—thiamine;
14
–4-hydroxybenzoate;
15
—an undeﬁned”sulfur donor” molecule;
16
—lipoic acid;
17
—choline;
18
—myo-inositol.
doi:10.1371/journal.pcbi.1004261.t002
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minimal number of reactions to complete pathways of interest. We used both the automated
gap-filling function of the RAVEN Toolbox (fillGaps) and manual gap-filling based on the in-
formation from the LLAMP database [18]. For instance, the threonine biosynthesis pathway in
ToxoNet1 was nearly complete but lacked a single enzyme, the homoserine dehydrogenase (E.
C. 1.1.1.3). The corresponding reaction (R01773) was included in the model without a gene as-
signed (i.e. as a “gap-fill”) justified by the presence of four other enzymes in the pathway and
the fact that the immediate downstream enzyme was identified in a proteomics study [26].
ToxoNet1 also retrieved a known issue of the lysine biosynthesis pathway: the bacterial-type
pathway consisting of 9 enzymatic steps lacks enzymes annotated for 4 sequential steps, mak-
ing the presence of the functional pathway debatable. While this issue remains unresolved, we
decided not to gap-fill this pathway in the model, thus, leaving lysine an essential amino acid.
The full list of gap-fill reactions included in ToxoNet1 is provided in S3 Table.
Importantly, some of the information necessary for a metabolic model could not be easily
deduced from the genome sequences alone. This is why we merged the draft output metabolic
network from the RAVEN Toolbox with a small-scale model of central carbon metabolism in
T. gondii. We manually built such a model prior to this study based on the genome annotation
from ToxoDB and refined it according to the relevant primary literature. This model contained
a number of recent experimental findings as well as manually assembled complex gene-reac-
tion associations. Among these were the pyruvate dehydrogenase activity that can be carried
out by the branched-chain keto-acid dehydrogenase complex (BCKDH) in the mitochondrion
[27], mitochondrial pyruvate transporter [28–30] and the GABA-shunt connected to the tri-
carboxylic acid (TCA) cycle [3].
Substrate dispensability based on ToxoNet1
One of the major challenges in simulation of parasite metabolism in silico is the unknown
range of metabolites available for the parasite within the host cell. As extracellular replication
(axenic cultivation) of T. gondii is not possible, it remains undefined which of the substrates
are dispensable for the parasite and which are not.
To address this issue in silico, we developed a method to enumerate all of the smallest/ mini-
mal metabolite sets (further referred to as in silicominimal medium or IMM), which could en-
able simulation of growth in ToxoNet1. In brief, the algorithm applied iterative rounds of
biomass production using the fewest number of substrates possible. After each of the iterations
we added a constraint to ensure that the next IMM included at least one substrate uncommon
from the preceding ones (further details on the formulation of the algorithm are described in
the materials and methods section).
The results of these simulations showed that as few as 19 substrates were sufficient for simu-
lation of T. gondii replication in ToxoNet1. We also observed a relatively large number (2592)
of alternative sets of 19 substrates with 10 metabolites being constitutively present in all the
IMMs. The other 9 substrates could be substituted by at least one other host-supplied metabo-
lite (Table 3). Despite the very large theoretical number of combinations (in the case of 9 vari-
able substrates picked from 220) we observed only 2592 alternative IMM of 19 substrates. This
indicates the ability of ToxoNet1 to substitute one substrate with another from the set of 230 is
rather limited. Indeed, the majority of the 2592 IMMs arise from flexibility in the carbon source
(one out of 7 available) and a source of nicotinate moiety (one out of 3). The other metabolites
are either non-substitutable (10) or substitutable with one single alternative. However, in this
particular analysis, we excluded the possibility of substituting one metabolite with simulta-
neous uptakes of several others, as it would lead to more than the minimal number of
substrates used.
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Gene essentiality predicted by ToxoNet1
We simulated in silico the outcomes of systematic removal of genes and reactions in ToxoNet1
to explore which of them represent indispensable metabolic functions. With the full set of 230
host-supplied substrates out of the 527 genes in ToxoNet1, 53 genes were predicted to be essen-
tial (Table 4 and literature evidence [31–38]). Considering that most of the transport reactions
do not have known gene-reaction associations, we also simulated single reaction deletions.
This allowed us to assess the dispensability of metabolite transport across the compartments,
as well as metabolite exchanges between T. gondii and its host cell (Table 4 and S5 Table).
In addition to single gene and reaction essentiality, we also simulated double gene deletions
to reveal the pairs in which genes are not essential for replication on their own, yet deleterious
when disrupted together. A total of 20 pairs that caused such synergistic effect (synthetic lethal-
ity) are listed in S5 Table.
Gene essentiality predictions depend on the following important aspects of metabolism as rep-
resented in the model: (1) range of substrates that can enter the model (i.e. molecules that the par-
asite can take up from the infected host cell); (2) composition of the parasite cell represented as a
set of biomass precursor molecules (the concept of biomass objective functions is explained in
[39]); (3) the presence of alternative metabolic routes to produce biomass building blocks from
the different substrates. Assuming a very permissive range of 230 substrates as potentially accessi-
ble for the parasite we predicted a minimal set of essential genes and reactions. In consequence,
the number of genes predicted by ToxoNet1 as non-essential is likely to be overestimated. Yet
with this assumption the probability of incorrect prediction of genes to be essential is lower.
ToxoNet1 as a framework for in silico assessment of experimental
research questions
In order to evaluate whether ToxoNet1 predictions closely reflect the metabolic capabilities of
T. gondii observed experimentally in tissue culture, we chose to assess the importance of the
Table 3. Composition of the minimal in silicomedia that allows ToxoNet1 to simulate replication of T.
gondii.
Indispensable (biomass precursor for which it is necessary)
5,10-methyltetrahydrofolate (THF); cholesterol (itself); choline (phosphatidylcholine); L-arginine (proteins);
L-histidine (proteins); L-tryptophan (proteins); lipoate (lipoylation in mitochondrion); riboﬂavin (FAD); S-
adenosyl-L-homocysteine (purine nucleotides, methionine, SAM); thiamine (TPP)
Dispensable (multiple alternative precursors present in different minimal media sets)
C6 or C5 carbon source D-fructose or D-glucosamine or D-glucose or D-mannose or D-ribose or D-
sorbitol or 2-Deoxy-D-ribose
NAD/NADP precursors nicotinate or nicotinate-D-ribonucleoside or nicotinamide
Amino acids or
precursors
L-lysine or L-2-aminoadipate 6-semialdehyde
L-isoleucine or (S)-3-methyl-2-oxopentanoate
L-valine or 3-methyl-2-oxobutanoate
L-leucine or 4-methyl-2-oxo-pentanoate
L-phenylalanine or phenylpyruvate
Source of inorganic iron Fe2+ or heme
Source of inorganic
phosphate
orthophosphate or diphosphate
Abbreviations: FAD—ﬂavine-adenine dinucleotide, NAD—nicoticamide-adenine dinucleotide, NADP—NAD
phosphate, TPP—thiamine pyrophosphate, SAM—S-adenosyl-methionine, THF—tetrahydrofolate.
doi:10.1371/journal.pcbi.1004261.t003
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Table 4. Gene essentiality predictions of ToxoNet 1 and available literature evidence.
Gene identiﬁers Metabolic subsystem E.C.
identiﬁer
Essentiality of ortholog(s) in P.
falciparum*
Essentiality evidence
TGME49_264780 Amino sugar and nucleotide sugar
metabolism
2.7.7.23 no NA
TGME49_264650 5.4.2.3 NA
TGME49_309730 Antioxidative metabolism 1.8.1.7 yes NA
TGME49_298990 Biosynthesis of terpenoids 1.18.1.2 no Inhibition of the pathway [31],[32]
TGME49_316770 2.5.1.- NA
TGME49_269430 2.5.1.1 yes Inhibition of the pathway [31],[32]
TGME49_227420 1.17.1.2
TGME49_306260 2.7.7.60
TGME49_255690 4.6.1.12
TGME49_306550 2.7.1.148
TGME49_262430 1.17.7.1
TGME49_214850 1.1.1.267
TGME49_208820 2.2.1.7
TGME49_224490 2.5.1.1
2.5.1.10
TGME49_290600 Citrate cycle(TCA cycle) 6.2.1.5 no Growth reducing knockout [33]
TGME49_278910 Cysteine and methionine
metabolism
2.5.1.47 no orthologs NA
TGME49_225990 Fatty acid biosynthesis
(apicoplast)
2.3.1.39 no (not essential on blood- and
essential in liver stage)
Conditional knockout of apicoplast-
targeted acyl-carrier protein [34]
TGME49_217740 1.1.1.100
TGME49_206610 2.3.1.12
TGME49_231890 2.3.1.180 yes
TGME49_251930 1.3.1.9
TGME49_321570 4.2.1.-
TGME49_293590 2.3.1.179
TGME49_221320 6.4.1.2
6.3.4.14
TGME49_239710 Fructose and mannose
metabolism
5.4.2.8 no NA
TGME49_239250 Glycerolipid metabolism 2.7.1.107 no orthologs NA
TGME49_310280 Glycerophospholipid 2.7.7.14 no NA
TGME49_261480 metabolism 2.7.8.- Growth arrest upon inhibition [35]
TGME49_212130 3.1.1.3
2.3.1.-
no orthologs NA
TGME49_216930 2.7.7.15 yes Growth reducing knockout res-cued by
salvage from host [36]
TGME49_281980 2.7.7.41 NA
TGME49_233500 Glycolysis / Gluconeogenesis 5.3.1.1 yes NA
TGME49_207710 Inositol phosphate metabolism 2.7.8.11 yes NA
TGME49_315640 Lipoic acid biosynthesis 2.3.1.181 no Conditional knockout of apicoplast-
targeted acyl-carrier protein [34]
TGME49_226400 2.8.1.8
TGME49_271820 Lipoic acid metabolism in
mitochondrion
2.7.7.63 no NA
TGME49_269800 Nicotinate and nicotinamide
metabolism
6.3.5.1 yes NA
TGME49_244700 2.7.1.23
(Continued)
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two independent routes of cytosolic acetyl-CoA production in the rapidly dividing tachyzoite
stage (Fig 3A). Acetyl-CoA is an important molecule in central carbon metabolism that is in-
volved in many biochemical processes such as fatty acid synthesis (FAS type I pathway), fatty
acid chain elongation and acetylation of proteins, in particular histones. ToxoNet1 identified
two enzymes that can produce acetyl-CoA in the cytosol: (1) from acetate through the acetyl-
CoA synthase (ACS) reaction (TGME49_266640), (2) from TCA-derived citrate by ATP-cit-
rate lyase (ACL) (TGME49_223840), as shown in Fig 3A. Acetoacetate-CoA ligase
(TGME49_219230) produces acetoacetyl-CoA that can be converted to acetyl-CoA by the ace-
tyl-CoA acetyltransferase (TGME49_301120), which belongs to the fatty acid degradation
pathway in mitochondrion. We thus concluded that this is unlikely to be producing cytosolic
acetyl-CoA production due to the predicted mitochondrial localization of the two enzymes. In
further support of the importance of cytosolic acetyl-CoA production is the presence of a puta-
tive ortholog of the human acetyl-CoA transporter (AT1) in the T. gondii genome [40]. This
transporter was shown to localize at the endoplasmic reticulum (ER) membrane and to be es-
sential for the survival of eukaryotic cells by allowing import of acetyl-CoA from the cytosol to
the ER to acetylate proteins within this compartment. ToxoNet1 predicted ACS- and ACL-en-
coding genes to be fully dispensable when knocked out individually, however, their simulta-
neous knockout was predicted to be lethal (S5 Table).
Experimental investigation of acetyl-CoA biosynthesis in the cytosol and
its essentiality
To determine the localization and level of expression of ACS and ACL in T. gondii, we modi-
fied the endogenous locus (knock-in) by introducing a 3xTy-epitope tag at the C-terminal end
Table 4. (Continued)
Gene identiﬁers Metabolic subsystem E.C.
identiﬁer
Essentiality of ortholog(s) in P.
falciparum*
Essentiality evidence
TGME49_224900 Purine metabolism 2.7.4.3 no NA
TGME49_233110 1.1.1.205 yes NA
TGME49_242730 2.7.4.8
TGME49_230450 6.3.5.2
TGME49_257740 Pyrimidine metabolism 2.7.4.-
2.7.4.14
no NA
TGME49_249180 1.5.1.3
2.1.1.45
yes [37]
TGME49_306970 2.7.4.9 NA
TGME49_299210 6.3.4.2 NA
TGME49_305980 Pyruvate metabolism in apicoplast 1.8.1.4 no** NA
TGME49_299070 2.7.1.40 yes NA
TGME49_216740 Riboﬂavin metabolism 2.7.1.26 yes NA
TGME49_214280 2.7.7.2
TGME49_237200 Sphingolipid metabolism 1.14.-.- no orthologs NA
TGME49_316450 2.3.1.24 yes
TGME49_215250 Thiamine metabolism 2.7.6.2 yes NA
(NA denotes the cases when neither supporting nor contradicting literature reference could be found). Gene essentiality in P. falciparum is based on the
Supplementary Table 1 of the review manuscript [38].
doi:10.1371/journal.pcbi.1004261.t004
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Fig 3. Both ACS and ACL are dispensable in the tachyzoite stage of T. gondii. (A) Schematic representation of the two pathways to produce acetyl-CoA
in the cytosol of T. gondii. Abbreviations: AcCoA, acetyl-CoA; α-KG, α-ketoglutarate; Cit, citrate; Glc, glucose; Lac, lactate; Mal, malate; OAA, oxaloacetic
acid; Pyr, pyruvate; Suc, succinate. Enzymes in red: ACL, ATP-citrate lyase; ACS, Acetyl-CoA synthetase. (B) Scheme of the knock-in strategy used to
introduce a 3Ty-tag in the endogenous loci of ACS, ACL and AT1. (C) Localization of endogenous ACS, ACL and AT1 C-terminally Ty-tagged (ACS-3Ty,
ACL-3Ty and AT1-3Ty) in the cytoplasm, cytosol and endoplasmic reticulum respectively of intracellular parasites using anti-Ty as well as anti-GAP45 that
stains the periphery and DAPI which stains the nucleus of the parasite. (D) Immuno-blot of total lysates from Ku80ko parasites expressing the C-terminally
Ty-tagged endogenous ACS, ACL and AT1 proteins byWestern blot using anti-Ty antibodies. Anti-Profilin (Prf) represents a loading control. (E) Schematic
representation of the direct knockout strategy by double homologous recombination where ACS was replaced by the chloramphenicol resistance cassette
and ACL by the HXGPRT selection cassette. The position of the primers used to confirm the integration and the length of the PCR products are indicated.
PCRs performed on genomic DNA extracted from Ku80ko, ACSko and ACLko strains confirm the integration of the selection cassette and loss of the
corresponding gene locus. The sequences of the primers can be found in S7 Table. (F) Plaque assays performed with Ku80ko, ACSko and ACLko parasite
lines fixed after 7 days. No significant defect in the lytic cycle could be observed. (G) Intracellular growth assay performed on Ku80ko, ACSko and ACLko
strains by determining the number of parasites per vacuole 24h post infection. Data are represented as mean ± SD from 3 biological replicates.
doi:10.1371/journal.pcbi.1004261.g003
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of both genes in the RHku80ko (Ku80ko) background strain, which limits random integration
in the genome hence facilitating recovery of homologous recombination events (Fig 3B). ACS
is clearly cytosolic and nuclear whereas ACL appears to localize mostly to the cytosol, whilst a
fainter nuclear staining can also be detected by indirect immunofluorescence assay (IFA) (Fig
3C). Localization of the acetyl-CoA transporter AT1 in the perinuclear region of the ER in T.
gondii was validated using the same knock-in tagging strategy (Fig 3B and 3C). Expression of
the epitope-tagged proteins was further validated by Western blot analyses, where ACS runs at
the expected molecular weight of ~80 kDa, ACL at ~140 kDa and AT1 at ~65 KDa (Fig 3D).
Comparative signal intensity observed onWestern blots suggests that ACS is significantly
more abundant than ACL and AT1.
To functionally assess the importance of both routes to produce cytosolic acetyl-CoA and
challenge the predictions made by ToxoNet1, individual deletion of the genes encoding ACL
and ACS were achieved using a double homologous recombination strategy (ACLko and
ACSko respectively) in Ku80ko (Fig 3E). For both genes, transgenic parasites were readily ob-
tained and cloned. Absence of the ACL and ACS ORFs and their replacement by a selection
cassette in individual clones was validated by genomic PCR (Fig 3E), thus, supporting the pre-
diction made by the model that these genes are both dispensable for the survival of T. gondii
tachyzoites. No significant defect could be observed in the overall lytic cycle of these knockout
mutants as represented by plaque assays performed in human foreskin fibroblast (HFF) mono-
layers. Indeed, both ACLko and ACSko parasites formed lysis plaques of similar sizes when
compared to wild type (Ku80ko) parasites (Fig 3F). Moreover, after 24h of intracellular growth,
most vacuoles of the ACLko strain contained 4 to 8 parasites, which is comparable to the num-
ber of parasites per vacuole for cells infected with Ku80ko or ACSko (Fig 3G). Finally, growth
competition assays between mutants and wt parasites, which would detect mild loss of fitness,
showed no significant defect either.
In order to assess whether a double knockout of ACS and ACL is lethal for T. gondii as sug-
gested by ToxoNet1, we first attempted to disrupt ACL by single homologous recombination
in the middle of the ORF in the ACSko parasite background (same strategy as presented in Fig
3B but leading to a truncation of the protein and removal of the catalytic site). While we were
able to interrupt the ACL gene in Ku80ko parasites, we failed to generate such a mutant in the
ACSko background. This result strongly suggested that ACS and ACL together are critical for
the biosynthesis of cytosolic acetyl-CoA. To further confirm the synthetic lethality between
ACS and ACL we generated a conditional knockdown of ACL in Ku80ko and in ACSko by U1
snRNP-mediated gene silencing with Cre-recombinase dependent positioning of U1, as has
been recently developed in T. gondii [41] (generating ACL-lox and ACSko/ACL-lox respective-
ly; Fig 4A). Following Cre-mediated recombination, the endogenous 3’untranslated region is
excised and a U1 recognition site is placed adjacent to the termination codon. Consequently
the ACL pre-mRNAs are cleaved at the 3’-end and degraded, leading to a highly efficient
knockdown of the gene. Loss at the protein level can be assessed by immuno-detection of the
C-terminal 3Ty-tag (Fig 4A). Correct integration of the construct was confirmed by genomic
PCR (Fig 4B). Importantly, upon deletion of ACS the level of endogenous ACL protein was sig-
nificantly increased compared to ACL-lox (Fig 4C). This change in level of ACL in the absence
of ACS was reproducibly confirmed by generation of a second independent transgenic parasite
line where the ACS gene was disrupted in the ACL-lox background strain (Fig 4D).
To conditionally disrupt ACL in the ACSko, the ACL-lox and ACSko/ACL-lox parasites
were transfected with a plasmid transiently expressing the Cre recombinase. While ACL-lox
excised parasites could be readily propagated in culture the ACSko/ACL-lox excised parasites
were lost after the first passage as monitored by genomic PCR analyses of the two excised para-
site populations. While genomic recombination of excised parasites could be readily detected
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in the original transfected parasites (P0), the signal was lost immediately after the first passage
of these cultures (P1 and P2) (Fig 5A) indicating a rapid deleterious effect. Thirty hours post
transfection of Cre recombinase, the loss of ACL-3Ty-tagged protein was evident by IFA in
about 50% of the ACL-lox and ACSko/ACL-lox vacuoles. While ACL-lox parasites lacking
ACL could be propagated in culture, parasites lacking ACL in the ACSko/ACL-lox strain were
immediately lost in the first culture passage (Fig 5B). While ACL-lox excised parasites ap-
peared normal, most vacuoles from excised ACSko/ACL-lox parasites exhibited a severe mor-
phological defect and impairment in the parasite division process with a loss of pellicle
integrity as seen by perturbation of GAP45 staining (Fig 5C). Furthermore these parasites ap-
pear to continue dividing their nuclei, mitochondrion and apicoplast, but fail to form daughter
cells, resulting in organelle accumulation in the vacuolar space (Fig 5C).
To determine whether the deleterious phenotype and loss of pellicle integrity could be at-
tributed to a block in type I fatty acid synthesis following depletion in cytosolic acetyl-CoA, the
gene coding for T. gondii FASI was disrupted in wild type RH strain parasites by CRISPR/Cas9
mediated genome editing [42]. Trangenic parasites were obtained following double-stranded
breaks generated by Cas9 at a position downstream of the FASI ATG. Two independent clones
were sequenced to confirm the introduction of frame shift mutations (S1A Fig) No defect in
the lytic cycle could be observed in these parasites (S1B Fig), which is in accordance with the
ToxoNet1 prediction that FASI activity is not essential for parasite survival. Taken together,
Fig 4. Generation of an inducible ACL knockdown in ACSko parasites. (A) Schematic representation of the U1 snRNP-mediated ACL gene silencing
with Cre-recombinase dependent positioning of U1 in Ku80ko wildtype and ACSko parasites. (B) PCRs performed on genomic DNA extracted from Ku80ko,
ACL-lox, ACSko/ACL-lox validating integration of the pKI-ACL-3TyLox3’UTRLoxU1 construct to knock down ACL in the different strains. The sequences of
the primers can be found in S7 Table (C and D). Immuno-blot of total lysates from ACL-lox, ACSko/ACL-lox where ACL-lox was integrated in the ACSko
strain or ACS was knocked out in ACL-lox. Both independent lines show increased levels of ACL when ACS is absent. Western blot was performed using
anti-Ty antibodies. Anti-TgProfilin (Prf) represents a loading control.
doi:10.1371/journal.pcbi.1004261.g004
Metabolic Needs and Capabilities of T. gondii
PLOS Computational Biology | DOI:10.1371/journal.pcbi.1004261 May 22, 2015 14 / 28
Fig 5. ACS and ACL are dually essential. (A) Following transfection of ACL-lox and ACSko/ACL-lox with
Cre recombinase, excision and repositioning of U1 is followed by genomic PCRs over several culture
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these data firmly support the predictions made by the model regarding the individual dispens-
ability of ACS and ACL and the synthetic lethality of ACL in the absence of ACS.
Discussion
ToxoNet1 constitutes a full genome-scale reconstruction of metabolism within T. gondii,
which can simulate growth of the parasite in silico and infer essentiality of its genes. It consider-
ably extends the scope of previous work [10] and contributes to better understanding of the
limits in the metabolic capabilities of this opportunistic human and animal pathogen. While
the modelling efforts of Song et al were aiming to reveal strain-type specific differences in me-
tabolism of T. gondii, in the present study we reconstructed an independent model that repre-
sents the potential scope of the metabolic capabilities of the parasite independently of the life-
stage and strain-type. Aiming at the most reliable gene essentiality predictions we used many
alternative assumptions on the range of accessible substrates and transportability of metabo-
lites. We have also achieved more comprehensive coverage of all the metabolic capabilities of
the parasite and implemented functional gene-protein-reaction associations enabling rigorous
gene deletions studies. Hereafter we provide a more in depth discussion on the key aspects of
our approach.
There are two distinct approaches for model reconstruction process that are commonly re-
ferred to as top-down and bottom-up [43]. The top-down approach is usually applied when de-
tailed experimental data about the majority of individual system components is scarce.
Conversely, for the bottom-up approach, a significant body of relevant primary literature is a
necessary prerequisite. These two approaches are very much complementary and this is why
increasingly more studies combine them in order to achieve the best results. This was also the
case in the ToxoNet1 reconstruction efforts: the first draft model was a hybrid of the output
generated by RAVEN Toolbox and a significantly smaller manually reconstructed (and highly
curated) model, which was built upon the similar model of P. falciparum [44] used as a tem-
plate. This bottom-up small-scale model allowed capturing of the features that were not identi-
fied by functional annotations, such as formation of multi-enzyme complexes for certain
enzymatic activities (e.g. the mitochondrial BCKDH complex that carries out the pyruvate de-
hydrogenase function [27]) as well as cofactor specificities for the enzymes.
Genes with metabolic functions in ToxoNet1 represent a modest fraction (c.a. 9%) of the T.
gondii protein-coding genes, which is comparable but greater than in the genome-scale models
of P. falciparum (7%) [8], L.major (6.7%) [20] and Cryptosporidium hominis (5.5%) [7]. Tox-
oNet1 provides a broader and more complete coverage of the metabolic capabilities of the para-
site with 145 additional enzyme-coding genes (38% greater) compared to the earlier metabolic
model of T. gondii [10]. Comparison of the number of metabolic reactions with the genome-
passages (every 48h) using primers P17/P18 as depicted in Fig 4A (P0, extracellular parasites 48h after Cre
transfection; P1, extracellular parasites passaged once ~96h post transfection; P2, extracellular parasites
passaged twice ~140h post transfection). (B) Histogram showing percentage of excised parasites over
several passages (every 48h) in ACL-lox and ACSko/ACL-lox populations following transfection with Cre
recombinase. Excised parasites were visualized by IFA looking for loss of ACL-3Ty signal. Due to fluctuation
in transfection efficiency, data from one biological replicate is shown and represents mean ± SD from 3
technical replicates. 3 biological replicates were done and gave the same results. (P0, intracellular parasites
30h after Cre transfection; P1, intracellular parasites passaged once ~72h post transfection; P2, intracellular
parasites passaged twice ~100h post transfection). (C) Immunofluorescence assay confirms the loss of ACL-
3Ty and parasite pellicle integrity in a subset of vacuoles 30h following transfection of ACL-lox and ACSko/
ACL-lox strains with a Cre recombinase expressing plasmid. IFAs were stained using anti-Ty, anti-GAP45
(Pellicle), anti-5F4 (mitochondrion) or anti-Atrx1 (apicoplast) antibodies and DAPI (nucleus). Arrowheads
highlight nuclear and mitochondrial material lost in the vacuolar space and loss of the apicoplast due to loss
of pellicle integrity.
doi:10.1371/journal.pcbi.1004261.g005
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scale models of the malaria parasite P. falciparum [8,9,13] confirms the common view that T.
gondii possesses broader metabolic capabilities (Table 5). These differences in metabolic capa-
bilities could be partially responsible for the observations that T. gondii can infect a very broad
range of cell types for asexual replication, while Plasmodium spp. can only replicate within
specific tissues.
ToxoNet1 contains confidence estimates (e-values and bit-scores) for each gene annotated as
encoding certain metabolic activities. This has allowed us to suggest a number of metabolic
functions for genes that did not have annotations with E.C. numbers in the ToxoDB database
(S4 Table). For example, TGME49_237140 (an “ethylene-inducible protein” in ToxoDB without
an E.C. identifier) was annotated as pyridoxal 5'-phosphate synthase pdxS subunit (E.C. 4.3.3.6)
with very high confidence estimates (e-value 5.30x10-141 and bit-score 479). Accordingly, an
orthologous gene (PF3D7_0621200) is annotated as pyridoxine biosynthesis protein (PDX1) in
P. falciparum, yet without an E.C. number assigned. There was also a set of genes with low confi-
dence in their function, despite their annotation in ToxoDB (e.g. TGME49_305840 had a low
sequence identity to known nicotinate-nucleotide adenylyltransferases with an e-value of
4.70x10-15 and a bit-score of 60.6). These two examples demonstrate the potential of the
RAVEN Toolbox to improve genome annotation and produce models with confidence esti-
mates that enable evaluation and, potentially, future corrections of the existing models.
ToxoNet1 contains 260 unique dead-end metabolites, which currently can be only produced
or only consumed in the network. We kept them in the model in order to allow future develop-
ments and expansion of the scope of the model. Further definition of the metabolic routes can
utilise these dead-end metabolites and contribute to a more complete understanding of the
metabolic capabilities of the parasite. For instance, the tRNAs loaded with the respective amino
acids were included to enable future extension of the model to the representation of protein
synthesis.
We chose to impose relaxed constraints in terms of subcellular compartments due to rather
high uncertainty in subcellular localisation of the enzymes as well as largely unknown capabili-
ties of the parasite to transport metabolites across its organellar membranes. We assigned the
enzymes with the corresponding reactions to their putative compartments and allowed a broad
range of metabolites to be transported across the compartment boundaries. This approach to
compartmentalisation ensures minimal bias in our results due to underestimated transport ca-
pabilities or incorrect assignment of enzymes to subcellular compartments. We expect subse-
quent refinements of ToxoNet1 with more stringent compartmentalisation as more reliable,
high-throughput computational and experimental methods are becoming available for subcel-
lular localisation of enzymes and functional annotation of transporter proteins in T. gondii.
Our objective of this work is to provide ToxoNet1 as a resource for the community and
Table 5. Comparison of the number of metabolites, reactions and genes between the models for T. gondii and P. falciparum.
Metabolic models of apicomplexan parasites Information about the models
Metabolites Reactions Genes Compartments
P. falciparum [9] 850 998 579 c, m, a, er, n, v, g
P. falciparum [8] 616 656 366 e, c, m, a
T. gondii [10] 384 400 382 c, m, a, er, im
T. gondii, this study 1019 1089 527 e, c, m, a
Abbreviations: e—extracellular space, c—cytosol, m—mitochondrion, a—apicoplast, n—nucleus, er—endoplasmic reticulum, g—Golgi complex, v—
digestive vacuole, im—mitochondrial intermembrane space.
doi:10.1371/journal.pcbi.1004261.t005
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therefore we avoided imposing constraints and hypotheses, which are not well-tested and con-
firmed that could contaminate the model and our results.
To understand the nutritional requirements of T. gondii, we implemented an algorithm that
identifies and ranks the minimal number of substrates required for growth in ToxoNet1. The re-
sults indicate that uptake of as few as 19 of 230 substrates allows the model to produce all bio-
mass building blocks. Moreover, we identified 2592 sets of 19 substrates that can allow growth,
and 10 substrates common to all these sets (Table 3). These 10 substrates are compounds that
are not synthesized de novo by T. gondii and are the precursors for biomass building blocks and
essential cofactors. Interestingly, the uptake of S-adenosyl-homocysteine provided precursors
for multiple biomass building blocks simultaneously (purine nucleotides, threonine, methionine
and their derivatives). Among the alternative substrates we identified 7 carbon sources: five hex-
oses and two pentoses (ribose and deoxyribose), which can be incorporated into the metabolism
by a ribokinase enzyme. Uptake of pentoses through a hexose transporter has been reported in
the protozoan parasite L.major and may potentially represent an additional level of versatility
in meeting the need of a carbon source, similarly to the previously observed in T. gondii utiliza-
tion of glutamine [45,46]. We could envision such need as the parasite uses various host cells,
where the set of available substrates may vary between cell types.
Validation of genome-scale models using metabolic tasks is an approach developed to evalu-
ate metabolic capabilities of the models in a systematic manner. To date it has been applied to
several models [11,47,48] for testing whether the major metabolic functions can be fulfilled
and the biochemical pathways that support these functions were represented correctly. Tox-
oNet1 is the first metabolic model of an apicomplexan parasite where the reconstruction pro-
cess involved the validation of metabolic tasks. Using this approach we explored the capability
of this pathogen to produce de novo biomass building blocks from glucose and inorganic sub-
stances. Interestingly, almost all the cofactors of metabolic enzymes, with the exception of pyri-
doxal phosphate cannot be produced de novo. Their synthesis required precursors that
contained certain chemical moieties (Table 2). This suggests that virtually all the metabolic
functions of the parasite depend on an adequate supply of specific precursors by the infected
host cell. Furthermore, we found that T. gondii requires uptake of almost all the amino acids,
which are essential for the host, with the possible exception of threonine (discussed below). No-
tably, T. gondii lacks the pathway for arginine synthesis, which can be produced by human
cells, however arginine is growth limiting for human cells because its de novo synthesis is insuf-
ficient and thus supplemental uptake is required [49]. This suggests that during infection and
growth of the parasite, the biosynthetic capabilities of the host can be significantly compro-
mised due to competition for essential and growth limiting amino acids and vitamins.
Threonine is the only amino acid essential for human cells and which T. gondii can poten-
tially produce. However, this pathway includes the enzyme homoserine dehydrogenase (E.C.
1.1.1.3), the encoding gene for which is not identified to date in the genome of the parasite.
Data from ToxoDB suggests that the genes encoding the enzymes of the threonine biosynthesis
pathway, namely aspartokinase (TGME49_227090), threonine synthase (TGME49_220840),
homoserine kinase (TGME49_216640) and aspartate-semialdehyde dehydrogenase
(TGME49_205420), are expressed at low levels in the tachyzoite stage. Homoserine kinase has
been detected in the proteome of oocysts [50], the infective forms of the parasite that can sur-
vive for extensive periods of time outside the host cell [51]. Taken together, these observations
indicate that the whole pathway from aspartate to threonine might not be functional in certain
life stages and therefore T. gondii could be a conditional threonine auxotroph. Should threo-
nine biosynthesis also be active in the other life stages it could represent a selective drug target
for inhibition of parasite replication without affecting the mammalian host cells. Maintenance
of some metabolite pools in T. gondiimay be a result of both uptake and de novo production.
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Hence, if the complete set of genes of a metabolic pathway is present in the genome of the para-
site, this pathway is not necessarily active and will not meet the demands of the parasite regard-
ing the products of the pathway. Fox et al. showed that salvage of pyrimidine nucleotides from
the host cell can support in vitro but not in vivo survival of T. gondiimutants with disrupted de
novo pyrimidine synthesis pathways [52]. Therefore, accurate consideration of metabolism in
the host and pathogen together is central for a better understanding of the metabolic needs and
capabilities of T. gondii.
Our study represents the first model-based gene essentiality predictions for T. gondii. The
earlier efforts to infer essentiality of genes in this parasite were reported by Gautam et al. [53].
Their approach for producing the list of putatively essential genes was largely dissimilar to ours
and relied on conservation of the enzymes across parasitic and free-living species with further
pruning based on the literature data. We believe that our modelling approach, which takes into
account many more inputs and constraints, produces more reliable gene essentiality predic-
tions, and it follows the standard modelling procedures established by the community [12,54].
Nevertheless, we consider that the part of the workflow proposed by Gautam et al. can be com-
plementary to our study, which also includes larger number genes with the updated functional
annotation we performed here. This future study will prioritise the putatively essential genes
according to their apparent utility as drug targets with minimal risk of off-target effects on the
host cell metabolism.
Using ToxoNet1 we predicted a minimal set of 53 enzyme-encoding genes to be indispens-
able for parasite replication within human cells. The majority of these genes (49 out of 53) have
orthologs in the malaria parasite P. falciparum and 32 of them were predicted as essential in
the existing metabolic models [38]. Evidence of essentiality for metabolic enzymes in T. gondii
is currently scarce, thus, we could not test the majority of our essentiality predictions (Table 5).
However, new technologies such as CRISPR/Cas9-mediated genome editing, hold promise of
forthcoming high-throughput gene knockout studies in various organisms including T. gondii
[42]. The dataset of experimentally established gene essentiality will provide an important vali-
dation of ToxoNet1 and a prerequisite for its further refinement and expansion.
We predicted synthetic essentiality of 20 pairs of genes, which represent two distinct cases.
In the first case the pair of genes encode two isoenzymes that catalyse the same reaction in the
same compartment. For example, the genes TGME49_318580 and TGME49_285980 encode
isoenzymes, which catalyse the phosphoglucomutase reaction (E.C. 5.4.2.2) and both were ex-
perimentally localised to the cytosol [33]. This reaction produces glucose-1-phophate in the cy-
tosol, which is an indispensable precursor for starch and nucleotide-sugar metabolism.
Therefore, simultaneous deletion of these two genes is a synthetic lethal. In the second case of
synthetic essentiality each gene encodes for an enzyme of a different reaction but with a com-
mon product, which is necessary for biomass synthesis. Thus, the two different enzymes can
substitute for each other (sometimes indirectly) for production of an essential metabolite. For
example, we established experimentally the synthetic lethality between the genes encoding ace-
tyl-CoA synthase (ACS) and ATP-citrate lyase (ACL), both of which produce acetyl-CoA in
the cytosol of the parasite. This central metabolite participates notably in fatty acid synthesis,
fatty acid chain elongation and in acetylation of proteins. We were able to rule out experimen-
tally that the severe phenotype observed upon depletion of cytosolic acetyl-CoA was due to an
impact on FASI since parasites lacking FASI did not exhibit any significant impairment in the
lytic cycle.
Moreover given that deletion of the genes coding for elongases previously reported [55] did
not phenocopy the lethality observed when attempting to delete ACS and ACL simultaneously,
we suspect that blockage of protein acylation might be responsible for the severe consequences
of deletion of cytosolic acetyl-CoA. In this context, we experimentally confirmed that the T.
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gondii acetyl-CoA transporter (AT1) is localized in the membrane of the ER and is anticipated
to deliver acetyl-CoA to the secretory pathway. It would be interesting to examine the impor-
tance AT1 for parasite survival. In contrast, the mitochondrion and the apicoplast should not
be affected since these compartments have their own routes for production of acetyl-CoA: (i)
in the apicoplast it is produced by the pyruvate dehydrogenase (PDH) complex [56], and (ii) in
the mitochondrion synthesis of acetyl-CoA is carried out by the BCKDH complex [27]. The
predicted synthetic lethality between ACS and ACL suggests that these are the only two signifi-
cant sources of acetyl-CoA in the cytosol, which was not assessed by previous experimental
studies and is formally demonstrated here.
Furthermore this synthetic lethality suggests that there is no, or no significant, transport of
acetyl-CoA to the cytosol from the mitochondrion or the apicoplast. This further confirms
that, unlike acetate, acetoacetate could not be a source of cytosolic acetyl-CoA and therefore
the metabolic role of acetoacetyl-CoA, considered to be a dead-end metabolite in ToxoNet1, re-
quires further investigation. Unexpectedly, the deletion of the gene coding for ACS leads to a
reproducible and immediate increase in abundance of ACL protein, a possible compensatory
adaptation that has not been reported previously. It is unclear whether the capacity of the para-
site to respond to the absence of ACS results from an increase at the level of transcription or
protein stability but this intriguing mechanism of adaptation deserves further investigation.
ToxoNet1 can assist in comprehensively embracing the various routes that T. gondii employs
to produce acetyl-CoA in different subcellular compartments.
Beyond this study ToxoNet1 can be used as a global metabolic context for integration and
interpretation of various high-throughput experimental data, similarly to the studies made in
P. falciparum and other eukaryotic pathogens [38]. Of particular interest is the integration of
experimental data collected on different life stages of T. gondii that will allow the model to
yield context-specific predictions and, potentially, reveal valid drug targets as well as funda-
mental knowledge regarding the stages implicated in persistence and transmission of this im-
portant human and animal pathogen.
Materials and Methods
Draft reconstruction of ToxoNet1
The reconstruction process started with generation of a draft metabolic network of T. gondii
based on the annotation of its protein sequences as extracted from the ToxoDB database [57].
Within the framework of the RAVEN Toolbox these protein sequences were compared to the
hidden Markov models (HMM) generated for each KEGG [17] orthology group [11]. In the
cases when e-values for the matches between a T. gondii protein and an HMM were smaller
than the specified e-value cutoff (10–20), the enzymatic reactions associated with the corre-
sponding KEGG orthology ID were added to the draft metabolic network. As a result we have
obtained a set of metabolic reactions linked to genetic loci of T. gondii. At this stage the model
did not contain information about either subcellular compartments, or about transport of me-
tabolites. We next merged this model with a manually curated, small-scale metabolic recon-
struction that we previously built based on the P. falciparummodel [44].
Similarly to Huthmatcher et al [9]., we removed reactions with generic metabolites (such as
“protein”, “dNTP”) and replaced non-unique metabolite identifiers with unique ones when
they corresponded to the biochemically equivalent entities (e.g. (S)-Lactate and L-lactate were
replaced with L-lactate).
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Compartmentalization
The parasitophorous vacuole (PV) space, which secludes T. gondii from the host cell cytosol, is
the outermost compartment represented in ToxoNet1. Extracellular compartment of the
model corresponds to the PV space. A eukaryotic organization of intracellular space of the par-
asite also includes a number of compartments, among which we chose to represent in Tox-
oNet1 the most relevant to metabolism, namely: mitochondrion, apicoplast and cytosol. The
following sequence-based localization predictors were used to suggest putative subcellular lo-
calization of the enzymes: TargetP [16] (version 1.1), MitoProt II [15] (version 1.101) and Api-
coAP [14] (version 1)). As an input data we used sequences of ORFs extracted from ToxoDB
(v.9, strain ME49) for the genes included in ToxoNet1. Computational localization predictions
were reconciled with the literature evidence for T. gondii and P. falciparum in the cases when
the latter were available (see S1 Table).
Transport reactions were included to link the majority of the metabolites in non-cytosolic
intracellular compartments with their cytosolic counterparts; such transports were not created
for phosphorylated metabolites or those that contained [acyl-carrier protein] ([ACP]) or Coen-
zyme A (CoA) moiety attached (with the exception of the apicoplast-to-cytosol transport of
IPP, and DMAPP as well as the mitochondrion-to-cytosol transport of ATP).
Metabolic tasks
Testing metabolic tasks is a built-in functionality of the RAVEN Toolbox [11] meant for verifi-
cation of correct metabolic capabilities in genome-scale models. Formulation of this function
allows one to test production of a certain metabolite(s) (or flux through particular reactions)
with strictly specified inlet and outlet of metabolites. For instance, a metabolic task “de novo
synthesis of ATP” was formulated as following: given unlimited uptake of glucose, oxygen, in-
organic phosphate, sulfate and ammonium, can the model produce ATP. The model failed to
accomplish this task, which is consistent with the literature knowledge about auxotrophy of T.
gondii for purines [58]. Thus, the task could be passed only when we added to the list of avail-
able compounds hypoxanthine, adenine or another molecule containing a purine moiety. In a
similar manner we have tested over a 60 metabolic tasks (all in S2 Table) to ensure realistic
metabolic capabilities of the model.
The range of available substrates
We simulated metabolism of the host cell using the most recent tissue-unspecific model of
human metabolism [19]. The Recon2 model was modified in terms of available substrates to
reflect growth on the defined minimal medium (Dulbecco's Modified Eagle's Medium with glu-
tamine and glucose). The PV which secludes the parasite from the host cell cytosol had been re-
ported as being permeable to small-molecule metabolites with molecular weights below 1500
Da [59] and thus imposes no relevant constraint to the metabolites we considered in ToxoNet1.
Thus, all the molecules that could be produced from the medium components in the cytosol of
the host cell were assumed to be potentially accessible for the parasite provided that they satisfy
the following criteria: host-supplied substrates were only small molecules (below 1.5 kDa) that
were not phosphorylated or bound to-CoA,-[ACP] or carnitine. We also assumed that the par-
asite could potentially dispose of a wide range of metabolic by-products from its cytosol into
the host cell. Thus, we added sink reactions for the same 230 metabolites that were assumed to
be host-supplied. As an exception we also allowed direct uptake into the cytosol of the follow-
ing five generic metabolites: “reduced acceptor”, “sulfur donor”, “acyl-CoA”, “carboxylate” and
“1-acylglycerol”; two non-generic metabolites: selenite and myo-inositol, and the appearance
of apoprotein in the mitochondrion and the apicoplast.
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Biomass composition
In order to simulate replication of the parasite and assess the essentiality of genes, reactions
and substrates, we assumed maximisation of flux through the biomass reaction to be the objec-
tive function of ToxoNet1. It represents cellular replication as a reaction that consumes pre-de-
fined amounts of metabolites defined as small-molecule biomass precursors as well as energy
in the form of ATP. We used the biomass reaction from the previous study [10] as a template
and introduced the following modifications: we extended this biomass reaction with the follow-
ing cofactors—NAD, NADP, FAD and lipoylated protein necessary for pyruvate dehydroge-
nase (PDH) activity in the mitochondrion and the apicoplast; we changed the compartment
for lipid precursors from endoplasmic reticulum (in Song et al. [10]) to the cytosol (no ER
compartment in ToxoNet1), and for L-lysine from mitochondrial to cytosol. The presence of
the mitochondrial pathway for L-lysine production remained obscure, thus in ToxoNet1 it is
acquired from the host instead of gap-filled de novo production in the parasite and sequestered
towards biomass from the cytosol.
Flux balance analysis (FBA) and substrate dispensability simulation
FBA is a standard computational approach for exploration of the metabolic capabilities repre-
sented in constraint-based models; principles, computational implementation of FBA as well
as the key assumptions are extensively described elsewhere [60].
In the absence of clear knowledge on the scope of substrates that the parasite can take up
from the host we made the following assumption: all the metabolites present in the host cell cy-
tosol are potentially accessible for the parasite except those that are phosphorylated, bound to
coenzyme A, acyl-carrier protein or carnitine. A list of molecules that satisfy these criteria was
generated using the recent tissue-unspecific model of human metabolism Recon2 [19] (the list
of the substrates is in S6 Table).
Minimal sets of metabolites necessary for the production of biomass were explored using an
in-house developed mixed-integer linear programming algorithm. For each of the exchange re-
actions that allowed uptake of a substrate into the model (i.e. 230 host-supplied metabolites)
we added one binary variable that denoted its utilization. Our algorithm solved the model sub-
ject to minimization of the sum of the binary variables thus yielding a minimal set of uptakes
that allowed the model to simulate growth. After each iteration the algorithm added one new
constraint to the model to assure that the following set would include at least one different up-
take reaction compared to all the previously generated ones. The iterations were repeated until
no more alternative sets of the same length could be found.
Essentiality studies
We performed simulation of gene deletion using a conventional approach [61] that implies
evaluation of gene-reaction associations that include the gene of interest, preventing flux
through corresponding metabolic reactions and an attempt to achieve a doubling time of 4.5
hours (specific growth rate of 0.15 h-1). Similar approaches were used for double gene deletion
studies—simultaneously blocking reactions associated with all pairs of genes that were not pre-
dicted as singularly essential. In reaction deletion simulations we blocked flux through every
single reaction in ToxoNet1 one at a time. Subsequent attempts at achieving the wild-type dou-
bling time in the absence of the reaction indicated whether the gene was dispensable or not.
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T. gondii strains and culture
T. gondii tachyzoites (RHku80-ko (Ku80ko), RHku80-ko/ACS-ko (ACSko), RHku80-ko/ACL-
ko (ACLko), RHku80-ko/ACL3Ty-LoxP3’UTRLoxP-U1 (ACL-lox), RHku80-ko/ACS-ko/
ACL3Ty-LoxP3’UTRLoxP-U1 (ACSko/ACL-lox), RH/FASIko (FASIko)) were grown in con-
fluent Human Foreskin Fibroblasts (HFF) and maintained in Dulbecco’s Modified Eagle’s Me-
dium (DMEM, Life technology, Invitrogen) supplemented with 5% foetal calf serum, 2 mM
glutamine and 25 μg/ml gentamicin in a humidified incubator at 37°C with 5% CO2.
Cloning of DNA constructs
All amplifications were performed with LA Taq (TaKaRa) polymerase and primers used are
listed in S7 Table.
Knock-in of ACS: (pKI-ACS-3Ty) The genomic fragment of ACS (TGME49_266640) was
amplified using primers ACS-1 and ACS-2 prior to digestion with with KpnI and SbfI and sub-
sequent cloning in the same sites of pTub8MIC13-3Ty-HXGPRT [62] to introduce 3 Ty-tags
at the C-terminus of the endogenous locus. Before transfection pKI-ACS-3Ty was linearized
with SnaBI.
Knock-in of AT1: (pKI-AT1-3Ty) The genomic fragment of AT-1 (TGME49_215940) was
amplified using primers AT1-1 and AT1-2 prior to digestion with KpnI and NsiI and subse-
quent cloning in the same sites of pTub8MIC13-3Ty-HXGPRT [62] to introduce 3 Ty-tags at
the C-terminus of the endogenous locus. Before transfection pKI-AT1-3Ty was linearized with
HindIII.
Knock-in and knock-down of ACL: (pKI-ACL-3Ty and pKI-ACL-3Ty-LoxP-3’UTR-LoxP-U1)
Genomic fragment of ACL (TGME49_223840) was amplified using primers ACL-1/ACL-2
and subsequently digested with KpnI and NsiI prior to cloning in the same sites of the pTub8-
MIC13-3Ty-HXGPRT for 3Ty-tag knock-in [62], or the modified C-terminal destabilization
vector pG152-3Ty-LoxP-3’UTRSag1-HXGPRT-LoxP-U1 [41]. Prior to transfection both plas-
mids were linearized with XhoI.
Knockout of ACS: (pTub-CAT-ACS-ko) around 1.5kb of the 5’ and 3’ flanking regions of
ACS were amplified using primers ACS-3/ACS-4 and ACS-5/ACS-6 respectively. The 5’ flank-
ing region was then cloned between KpnI and XhoI restriction sites of the pTub5-CAT and the
3’ flanking region between the BamHI and NotI sites. The plasmid was cut with KpnI and NotI
prior to transfection.
Knockout of ACL: (pTub-HXGPRT-ACL-ko) around 1.5kb of the 5’ and 3’ flanking regions
of ACL were amplified using primers ACL-3/ACL-4 and ACL-5/ACL-6 respectively. The 5’
flanking region was then cloned between the KpnI and XhoI sites of the p2855-HXGPRT plas-
mid and the 3’ flanking region between the BamHI and NotI sites. The plasmid was cut with
KpnI and NotI restriction enzymes prior to transfection.
Frameshift knockout of FASI using CRISPR/CAS9 plasmid [42]: This vector has been gener-
ated using the Q5 site-directed mutagenesis kit (New England Biolabs) with the vector pSAG1::
CAS9-U6::sgUPRT as template (a gift from Dr. L.D. Sibley). The UPRT-targeting gRNA was
replaced by the FASI (TGME49_294820) specific gRNA using the primer pairs gRNA-FASI/
gRNA-rev (gRNA highlighted in red in S7 Table).
Parasite transfection and selection of stable transformants
Parasite transfections were performed by electroporation as previously described [63].The
hxgprt gene was used as a positive selectable marker in the presence of mycophenolic acid
(25 μg/mL) and xanthine (50 μg/mL) for pKI-ACS-3Ty, pKI-AT1-3Ty, pKI-ACL-3Ty,
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pKI-ACL-3Ty-LoxP-3’UTR-LoxP-U1 and pTub-HXGPRT-ACL-ko vectors transfected in
Ku80ko or ACSko, as previously described [64].
Ku80ko was transfected with pTub-CAT-ACS-ko and 20μM chloramphenicol was used to
select resistant parasites.
Resistant parasites were cloned by limiting dilution in 96 well plates and clones were as-
sessed by genomic PCR.
To efficiently disrupt the FASI locus, 30 ug of the FASI gRNA-specific CRISPR/CAS9 vector
was transfected into wild type RH parasites. 48 hours after transfection, GFP positive parasites
were sorted by flow cytometry and cloned into 96-well plates using a Moflo Astrios (Beckman
Coulter). Individual clones were then analysed by sequencing.
Preparation of T. gondii genomic DNA
Genomic DNA was prepared from tachyzoites using the Wizard SV genomic DNA purification
system (Promega). Correct integration of the different constructs into the genome of the vari-
ous strains was determined by genomic PCR using GoTaq Green Master Mix (Promega).
Antibodies
The antibodies used in this study were described previously as follows: polyclonal rabbit anti-
GAP45, rabbit anti-TgProfilin [65], monoclonal mouse anti-Ty (BB2), mouse monoclonal
anti-F1-ATPase beta subunit (P. Bradley, unpublished) (5F4), mouse monoclonal anti-ATrx1
11G8 [66]. For Western blot analyses, secondary peroxidase conjugated goat anti-rabbit or
mouse antibodies (Molecular Probes) were used. For immunofluorescence analyses, the sec-
ondary antibodies Alexa Fluor 488 and Alexa Fluor 594-conjugated goat anti-mouse or rabbit
antibodies (Molecular Probes) were used.
Immunofluorescence assay (IFA) and confocal microscopy
Parasite-infected HFF cells seeded on cover slips were fixed with 4% paraformaldehyde/0.05%
glutaraldehyde (PFA/Glu) in PBS. Fixed cells were then processed as previously described [67].
Confocal images were generated with a Zeiss (LSM700, objective apochromat 63x/1.4 oil) laser
scanning confocal microscope at the Bioimaging core facility of the Faculty of Medicine, Uni-
versity of Geneva. Stacks of sections were processed with ImageJ and projected using the maxi-
mum projection tool.
Western blot analyses
Parasites were lysed in PBS-1% Triton X-100 and mixed with SDS–PAGE loading buffer under
reducing conditions. The suspension was subjected to sonication on ice. SDS-PAGE was per-
formed using standard methods. Separated proteins were transferred to nitrocellulose mem-
branes and probed with appropriate antibodies in 5% non-fat milk in PBS-0.05% Tween20.
Bound secondary peroxidase conjugated antibodies were visualized using the SuperSignal
(Pierce).
Phenotypic analyses
Plaque assays: HFF monolayers were infected with parasites and let to develop for 7 days before
fixation with PFA/Glu and Crystal Violet staining to visualize plaques.
Intracellular growth assays: HFFs were inoculated with parasites, washed 4h post infection
and coverslips were fixed at 24 h post-infection with 4% PFA/Glu and stained by IFA with
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rabbit anti-TgGAP45. Number of parasites per vacuole was counted in triplicate for each con-
dition (n = 3). More than 200 vacuoles were counted per replicate.
Software and databases
Flux-balance analysis was performed usingMATLAB (Version R2012b, TheMathWorks) with
CPLEX (ILOG IBM, version 12.51) andMosek (version 7) solvers; RAVENToolbox was used with-
inMatlab environment (version 1.07, downloaded from http://129.16.106.142/tools.php?c = raven).
Input data was taken from KEGG database (www.kegg.jp, up to date as of 18/11/2013), ToxoDB
(www.toxodb.org, version 9), ApiLoc database (http://apiloc.biochem.unimelb.edu.au/apiloc/apiloc,
version 3), and LLAMP portal (www.llamp.net, no evident version tracking).
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